1174020-48-4

Basic information

• Product Name: cis-3-fluoro-4-hydoxy-n- boc pyrroldine
• Synonyms: cis-3-fluoro-4-hydoxy-n- boc pyrroldine;tert-butyl (3S,4R)-3-fluoro-4-hydroxypyrrolidine-1-carboxylate;(3S,4R)-1-Boc-3-fluoro-4-hydroxypyrrolidine
• CAS NO: 1174020-48-4
• Molecular Formula: C9H16FNO3
• Molecular Weight: 205.23
• Mol File: 1174020-48-4.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: cis-3-fluoro-4-hydoxy-n- boc pyrroldine(CAS DataBase Reference)
• NIST Chemistry Reference: cis-3-fluoro-4-hydoxy-n- boc pyrroldine(1174020-48-4)
• EPA Substance Registry System: cis-3-fluoro-4-hydoxy-n- boc pyrroldine(1174020-48-4)

Safety Data

• Hazardous Substances Data: 1174020-48-4(Hazardous Substances Data)

Usage

General Description

Cis-3-fluoro-4-hydroxy-N-Boc pyrrolidine is a chemical compound with the molecular formula C9H16FNO3. It is a fluorinated derivative of the pyrrolidine family, containing a hydroxyl group and a Boc (tert-butoxycarbonyl) protective group on the nitrogen atom. cis-3-fluoro-4-hydoxy-n- boc pyrroldine is often used as a building block in organic synthesis, particularly in the pharmaceutical industry for the creation of potential drug candidates. It is also known for its potential use in the preparation of fluorinated compounds, which have shown promise in various applications including medicinal chemistry and agrochemicals. cis-3-fluoro-4-hydoxy-n- boc pyrroldine has properties that make it attractive for use in the creation of new chemical entities and is a valuable tool for drug discovery and development.

Upstream product

• 151259-38-0 tert-butyl diallylcarbamate 
• 114214-49-2 1-tert-butoxycarbonyl-3,4-epoxypyrrolidine 
• 73286-70-1 N-(tert-butoxycarbonyl)-3-pyrroline 

Relevant articles and documents

(HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY

Provided are a (hetero)arylamide compound as shown in formula (I) having an inhibitory effect on protein kinase activity, a pharmaceutically acceptable salt, a stereoisomer, a solvate or hydrate thereof, a pharmaceutical composition comprising the compound or a derivative thereof, and a method for preparing the compound. The compound can be used as an irreversible inhibitor for protein kinase for preparing a plurality of drugs comprising an anti-tumour drug.

5-PHENYLAZAINDOLE DERIVATIVE HAVING AMPK ACTIVATING EFFECT

Provided is a compound which is useful as an AMPK activator. A compound represented by formula: wherein X is substituted or unsubstituted monocyclic heterocyclyl or the like; ring A is substituted aryl, substituted heteroaryl, substituted cycloalkyl, substituted cycloalkenyl, or substituted heterocyclyl, wherein the ring A may further have a substituent(s) other than Y; Y is halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl or the like; R4, R5, R6 and R7 are each independently hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkyloxy, substituted or unsubstituted alkylthio, substituted or unsubstituted alkylsulfonyl, substituted or unsubstituted acyl, substituted or unsubstituted carbamoyl, substituted or unsubstituted sulfamoyl, or substituted or unsubstituted amino; R8 is hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl or the like; and R9 is hydrogen, halogen, hydroxy, cyano, nitro, carboxy, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl or the like, or its pharmaceutically acceptable salt.

HEPATITIS B ANTIVIRAL AGENTS

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.